Status:
COMPLETED
Psychotherapy Trial With Transgender Clients
Lead Sponsor:
University of Wisconsin, Madison
Conditions:
Transgender Persons, M01.777.500
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Transgender and gender diverse (TGD) individuals are at an increased risk for mental health concerns, including anxiety, trauma-based distress, depression, self-harm, and suicidality. Quantitative and...
Eligibility Criteria
Inclusion
- Age of 18 or older
- Fluent in written and spoken English
- Willingness to participate in pre/post/session-by-session assessments and 12 ----Individual psychotherapy treatment sessions
- Individual identifies as transgender, trans, or non-binary (or somewhere along the gender minority spectrum).
Exclusion
- Under 18 years old
- Reports current, unmanaged psychotic symptoms or symptoms requiring immediate inpatient treatment (e.g., hallucinations, delusions, threatening immediate suicidal behaviors)
- Currently engaging in psychotherapy
- Cannot attend therapy on Tuesdays from 2-7pm
- Individuals who lack the capacity to provide consent will be excluded.
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 10 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03369054
Start Date
December 1 2017
End Date
January 10 2019
Last Update
December 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin Madison
Madison, Wisconsin, United States, 53706